156 related articles for article (PubMed ID: 31121497)
1. Amino acid residues involved in the heparin-binding activity of murine IL-12 in the context of an antibody-cytokine fusion protein.
Luria-Pérez R; Candelaria PV; Daniels-Wells TR; Rodríguez JA; Helguera G; Penichet ML
Cytokine; 2019 Aug; 120():220-226. PubMed ID: 31121497
[TBL] [Abstract][Full Text] [Related]
2. A single-chain IL-12 IgG3 antibody fusion protein retains antibody specificity and IL-12 bioactivity and demonstrates antitumor activity.
Peng LS; Penichet ML; Morrison SL
J Immunol; 1999 Jul; 163(1):250-8. PubMed ID: 10384123
[TBL] [Abstract][Full Text] [Related]
3. IL-12 is a heparin-binding cytokine.
Hasan M; Najjam S; Gordon MY; Gibbs RV; Rider CC
J Immunol; 1999 Jan; 162(2):1064-70. PubMed ID: 9916734
[TBL] [Abstract][Full Text] [Related]
4. Anti-HER2/neu IgG3-(IL-2) and anti-HER2/neu IgG3-(GM-CSF) promote HER2/neu processing and presentation by dendritic cells: implications in immunotherapy and vaccination strategies.
Dela Cruz JS; Trinh KR; Chen HW; Ribas A; Morrison SL; Penichet ML
Mol Immunol; 2006 Feb; 43(6):667-76. PubMed ID: 15908002
[TBL] [Abstract][Full Text] [Related]
5. Vaccination with novel combinations of anti-HER2/neu cytokines fusion proteins and soluble protein antigen elicits a protective immune response against HER2/neu expressing tumors.
Helguera G; Dela Cruz JS; Lowe C; Ng PP; Trinh R; Morrison SL; Penichet ML
Vaccine; 2006 Jan; 24(3):304-16. PubMed ID: 16125282
[TBL] [Abstract][Full Text] [Related]
6. Modulation of Interleukin-12 activity in the presence of heparin.
Jayanthi S; Koppolu BP; Nguyen KG; Smith SG; Felber BK; Kumar TKS; Zaharoff DA
Sci Rep; 2017 Jul; 7(1):5360. PubMed ID: 28706183
[TBL] [Abstract][Full Text] [Related]
7. The localisation of the heparin binding sites of human and murine interleukin-12 within the carboxyterminal domain of the P40 subunit.
Garnier P; Mummery R; Forster MJ; Mulloy B; Gibbs RV; Rider CC
Cytokine; 2018 Oct; 110():159-168. PubMed ID: 29753267
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of antitumor activity of a single-chain interleukin-12 IgG3 antibody fusion protein (mscIL-12.her2.IgG3).
Peng LS; Penichet ML; Dela Cruz JS; Sampogna SL; Morrison SL
J Interferon Cytokine Res; 2001 Sep; 21(9):709-20. PubMed ID: 11576465
[TBL] [Abstract][Full Text] [Related]
9. Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity.
Ling P; Gately MK; Gubler U; Stern AS; Lin P; Hollfelder K; Su C; Pan YC; Hakimi J
J Immunol; 1995 Jan; 154(1):116-27. PubMed ID: 7527811
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of a dual cytokine/single-chain antibody fusion protein for simultaneous delivery of GM-CSF and IL-2 to Ep-CAM expressing tumor cells.
Schanzer JM; Fichtner I; Baeuerle PA; Kufer P
J Immunother; 2006; 29(5):477-88. PubMed ID: 16971804
[TBL] [Abstract][Full Text] [Related]
11. Efficient production and purification of recombinant human interleukin-12 (IL-12) overexpressed in mammalian cells without affinity tag.
Jayanthi S; Koppolu Bp; Smith SG; Jalah R; Bear J; Rosati M; Pavlakis GN; Felber BK; Zaharoff DA; Kumar TK
Protein Expr Purif; 2014 Oct; 102():76-84. PubMed ID: 25123642
[TBL] [Abstract][Full Text] [Related]
12. Bi-functional cytokine fusion proteins for gene therapy and antibody-targeted treatment of cancer.
Gillies SD; Lan Y; Brunkhorst B; Wong WK; Li Y; Lo KM
Cancer Immunol Immunother; 2002 Oct; 51(8):449-60. PubMed ID: 12202906
[TBL] [Abstract][Full Text] [Related]
13. A recombinant IgG3-(IL-2) fusion protein for the treatment of human HER2/neu expressing tumors.
Penichet ML; Dela Cruz JS; Shin SU; Morrison SL
Hum Antibodies; 2001; 10(1):43-9. PubMed ID: 11455061
[TBL] [Abstract][Full Text] [Related]
14. A RANTES-antibody fusion protein retains antigen specificity and chemokine function.
Challita-Eid PM; Abboud CN; Morrison SL; Penichet ML; Rosell KE; Poles T; Hilchey SP; Planelles V; Rosenblatt JD
J Immunol; 1998 Oct; 161(7):3729-36. PubMed ID: 9759898
[TBL] [Abstract][Full Text] [Related]
15. Identification of single amino acid residues of human IL-6 involved in receptor binding and signal initiation.
Ehlers M; Grötzinger J; Fischer M; Bos HK; Brakenhoff JP; Rose-John S
J Interferon Cytokine Res; 1996 Aug; 16(8):569-76. PubMed ID: 8877726
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of heparin-induced modulation of human interleukin 12 bioactivity.
Nguyen KG; Gillam FB; Hopkins JJ; Jayanthi S; Gundampati RK; Su G; Bear J; Pilkington GR; Jalah R; Felber BK; Liu J; Thallapuranam SK; Zaharoff DA
J Biol Chem; 2019 Mar; 294(12):4412-4424. PubMed ID: 30670588
[TBL] [Abstract][Full Text] [Related]
17. Recombinant anti-human HER2/neu IgG3-(GM-CSF) fusion protein retains antigen specificity and cytokine function and demonstrates antitumor activity.
Dela Cruz JS; Trinh KR; Morrison SL; Penichet ML
J Immunol; 2000 Nov; 165(9):5112-21. PubMed ID: 11046042
[TBL] [Abstract][Full Text] [Related]
18. Mapping a heparin binding site on ErbB-3 epidermal growth factor receptor.
Adar R; Yayon A
Biochem Biophys Res Commun; 2001 Apr; 283(1):1-5. PubMed ID: 11322758
[TBL] [Abstract][Full Text] [Related]
19. A receptor binding domain of mouse interleukin-4 defined by a solid-phase binding assay and in vitro mutagenesis.
Morrison BW; Leder P
J Biol Chem; 1992 Jun; 267(17):11957-63. PubMed ID: 1601864
[TBL] [Abstract][Full Text] [Related]
20. Further characterization of the binding of human recombinant interleukin 2 to heparin and identification of putative binding sites.
Najjam S; Mulloy B; Theze J; Gordon M; Gibbs R; Rider CC
Glycobiology; 1998 May; 8(5):509-16. PubMed ID: 9597549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
